BioRender Icon

Oligodendrocyte (myelinating) 2

Oligodendrocyte (myelinating) 2 - Editable icon of Oligodendrocyte (myelinating) 2
[{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d090ff2/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d090ff2/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d090ff3/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d090ff3/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d090ff4/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d090ff4/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d090ff5/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d090ff5/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d090ff6/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d090ff6/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d090ff7/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d090ff7/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d090ff8/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d090ff8/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d090ff9/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d090ff9/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d090ffa/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d090ffa/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d090ffb/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d090ffb/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d090ffc/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d090ffc/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d090ffd/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d090ffd/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d090ffe/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d090ffe/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d090fff/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d090fff/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d091000/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d091000/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d091001/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d091001/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d091002/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d091002/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d091003/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d091003/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d091004/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d091004/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d091005/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d091005/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d091006/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d091006/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d091007/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d091007/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d091008/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d091008/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d091009/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d091009/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d09100a/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d09100a/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d09100b/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d09100b/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d09100c/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d09100c/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d09100d/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d09100d/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d09100e/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d09100e/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d09100f/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d09100f/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d091010/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d091010/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d091011/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d091011/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d091012/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d091012/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d091013/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d091013/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d091014/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d091014/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d091015/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d091015/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d091016/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d091016/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d091017/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d091017/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d091018/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d091018/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d091019/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d091019/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d09101a/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d09101a/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d09101b/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d09101b/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d09101c/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d09101c/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d09101d/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d09101d/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d09101e/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d09101e/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d09101f/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d09101f/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d091020/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d091020/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d091021/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d091021/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d091022/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d091022/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d091023/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d091023/5d8b843cb1457b0004a60f10.png"}]
Use This Icon – Free
No credit card required to sign up.

This icon is fully editable in BioRender

  • Add text, shapes, & other icons
  • Search 50,000+ scientifically accurate icons
  • Recolor and rearrange every icon, line, & label
  • Export or share for any use case
Scientist Avatars

Join 4M+ scientists already making publication-ready figures

Go from icons to finished figure – in minutes

  • Search from 50,000+ scientifically accurate, peer-reviewed icons
  • Customize with labels, shapes, and additional icons – everything is completely editable
  • Export or share your figures with collaborators

Not quite the right icon? Discover more.

Search 50,000+ icons across 30+ life-science fields.

search icon
arrow-right
Keywords
neuroglia,axon,pns,peripheral nervous system,myelination,myelin,myelin sheath,oligodendrocyte,oligodendroglia,myelinating oligodendrocyte
View More

Try a synonym, or sign up to request an icon from the app.

Image types

Oligodendrocyte (myelinating) 2 icon JPEG

Oligodendrocyte (myelinating) 2 icon PNG

Oligodendrocyte (myelinating) 2 icon SVG

Oligodendrocyte (myelinating) 2 icon GIF

Biorender Icon FAQs

How are scientists using the Oligodendrocyte (myelinating) 2 icon in their work?

BioRender users often use the Oligodendrocyte (myelinating) 2 icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Cell Types.

Can I use this icon in a BioRender figure or scientific illustration?

Yes, the Oligodendrocyte (myelinating) 2 is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the Oligodendrocyte (myelinating) 2 icon customizable in BioRender?

Most icons in BioRender, including the Oligodendrocyte (myelinating) 2 icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

Can I export figures that include the Oligodendrocyte (myelinating) 2 icon for publication or presentations?

Yes, figures containing the Oligodendrocyte (myelinating) 2 icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

How do I cite BioRender if I use this icon?

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

Is the Oligodendrocyte (myelinating) 2 icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the Oligodendrocyte (myelinating) 2 icon — especially those focused on Cell Types. You can search BioRender’s template library or add this icon manually to any canvas.

What is BioRender?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this Oligodendrocyte (myelinating) 2 icon along with our library of more than 30,000 life science icons.

Looking for science content?

Browse 50K+ icons and templates that are peer-reviewed, easy to use, and free.

Find yours now
x icon